Pan-specific and partially selective dye-labeled peptidic inhibitors of the polycomb paralog proteins

Bioorg Med Chem. 2020 Jan 1;28(1):115176. doi: 10.1016/j.bmc.2019.115176. Epub 2019 Nov 9.

Abstract

Epigenetic regulation of gene expression is in part controlled by post-translational modifications on histone proteins. Histone methylation is a key epigenetic mark that controls gene transcription and repression. There are five human polycomb paralog proteins (Cbx2/4/6/7/8) that use their chromodomains to recognize trimethylated lysine 27 on histone 3 (H3K27me3). Recognition of the methyllysine side chain is achieved through multiple cation-pi interactions within an 'aromatic cage' motif. Despite high structural similarity within the chromodomains of this protein family, they each have unique functional roles and are linked to different cancers. Selective inhibition of different CBX proteins is desirable for both fundamental studies and potential therapeutic applications. We report here on a series of peptidic inhibitors that target certain polycomb paralogs. We have identified peptidic scaffolds with sub-micromolar potency, and will report examples that are pan-specific and that are partially selective for individual members within the family. These results highlight important structure-activity relationships that allow for differential binding to be achieved through interactions outside of the methyllysine-binding aromatic cage motif.

Keywords: CBX; Epigenetics; Methyllysine reader proteins; Peptidomimetics; Polycomb paralogs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Dose-Response Relationship, Drug
  • Humans
  • Molecular Structure
  • Peptides / chemical synthesis
  • Peptides / chemistry
  • Peptides / pharmacology*
  • Polycomb-Group Proteins / antagonists & inhibitors*
  • Polycomb-Group Proteins / genetics
  • Structure-Activity Relationship

Substances

  • Peptides
  • Polycomb-Group Proteins